Literature DB >> 6404446

Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia.

J M Ekue, A M Ulrich, E K Njelesani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6404446      PMCID： PMC1547656          DOI： 10.1136/bmj.286.6374.1315-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  Mefloquine (WR 142,490) in the treatment of human malaria.

Authors:  C M Trenholme; R L Williams; R E Desjardins; H Frischer; P E Carson; K H Rieckmann; C J Canfield
Journal:  Science       Date:  1975-11-21       Impact factor: 47.728

2.  Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist.

Authors:  C C Campbell; W Chin; W E Collins; S M Teutsch; D M Moss
Journal:  Lancet       Date:  1979-12-01       Impact factor: 79.321

3.  Chloroquine-resistant Plasmodium falciparum malaria in Kenya.

Authors:  S Fogh; S Jepsen; P Effersøe
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184
  3 in total
  12 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

2.  Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria.

Authors:  Tolu O Odugbemi; Odunayo R Akinsulire; Ibukun E Aibinu; Peter O Fabeku
Journal:  Afr J Tradit Complement Altern Med       Date:  2006-11-13

3.  Chloroquine resistant Plasmodium falciparum malaria in Zimbabwe.

Authors:  S L Mutambu; A B Dallas; C L Olweny
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

4.  [Drug resistance of Plasmodium falciparum in Burundi].

Authors:  M H Coosemans; L Hendrix; M Barutwanayo; G Butoyi; E Onori
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

5.  Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.

Authors:  T Harinasuta; D Bunnag; S Vanijanond; P Charoenlarp; P Suntharasmai; S Chitamas; U K Sheth; W H Wernsdorfer
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.

Authors:  J M Ekue; D E Phiri; U K Sheth; M Mukunyandela
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

7.  A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.

Authors:  J M Ekue; O O Simooya; U K Sheth; W H Wernsdorfer; E K Njelesani
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara.

Authors:  E Onori
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

9.  Operational scale entomological intervention for malaria control: strategies, achievements and challenges in Zambia.

Authors:  Emmanuel Chanda; Victor M Mukonka; Mulakwa Kamuliwo; Michael B Macdonald; Ubydul Haque
Journal:  Malar J       Date:  2013-01-08       Impact factor: 2.979

10.  Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.

Authors:  Michael Nambozi; Jean-Pierre Van Geertruyden; Sebastian Hachizovu; Mike Chaponda; Doreen Mukwamataba; Modest Mulenga; David Ubben; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-02-28       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.